Work

Talazoparib Tops Physician’s Choice for Advanced, BRCA-Positive Breast Cancer

Year: 2017

Type: article

Author: Dave Levitan

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946023013

FWCI:

Cites:

Cited by:

Related to: 10